Corlanor is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Ivabradine Hydrochloride.
| Product ID | 55513-813_17727cc4-117c-47b3-bf1d-bbc2968c51b6 |
| NDC | 55513-813 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Corlanor |
| Generic Name | Ivabradine |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209964 |
| Labeler Name | Amgen Inc |
| Substance Name | IVABRADINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/5mL |
| Pharm Classes | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC],Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-04-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209964 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-04-19 |
| Marketing Category | NDA |
| Application Number | NDA209964 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-04-19 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55513-800 | Corlanor | ivabradine |
| 55513-810 | Corlanor | ivabradine |
| 55513-813 | Corlanor | ivabradine |
| 70518-3309 | Corlanor | ivabradine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CORLANOR 79157808 4834147 Live/Registered |
BIOFARMA 2014-10-03 |
![]() CORLANOR 77684533 3751418 Live/Registered |
BIOFARMA 2009-03-05 |